B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

TRHR

MOLECULAR TARGET

thyrotropin releasing hormone receptor

UniProt: P34981NCBI Gene: 720119 compounds

TRHR (thyrotropin releasing hormone receptor) is targeted by 19 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting TRHR

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Hexachlorophene2.309
2Riboflavin Nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables.1.795
3Lithocholic Acid1.614
4Cetylpyridinium Cationic bactericidal surfactant used as1.393
5Arecoline1.102
6Lovastatin1.102
7Thioridazine1.102
8Budesonide0.691
920-alpha-Dihydroprogesterone0.691
10Acetaldehyde0.691
11Calcimycin0.691
12candesartan cilexetil [Supplementary Concept]0.691
13Clotrimazole0.691
14Dihydrotestosterone0.691
15Monocrotaline0.691
16Niacin0.691
17Promethazine0.691
18Tinidazole0.691
19triflupromazine hydrochloride0.691

About TRHR as a Drug Target

TRHR (thyrotropin releasing hormone receptor) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 19 compounds with documented TRHR interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

TRHR inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.